Background: Around 10 million people worldwide contract tuberculosis every year.
According to the World Health Organization (WHO), approximately one-quarter of the world's …

Tuberculosis (TB) is a health threat to the global population. Anti-TB drugs and vaccines are
key approaches for TB prevention and control. TB animal models are basic tools for …

SETTING: In 2005, in response to the increasing prevalence of rifampicin-resistant
tuberculosis (RR-TB) and poor treatment outcomes, Rwanda initiated the programmatic …

Health promotion is an educational tool that can be used to educate and create awareness
of health issues through various media forms. The purpose of this study was to explore the …

Amplification of drug resistance in Mycobacterium tuberculosis (M. tb) and its transmission
are significant barriers in controlling tuberculosis (TB) globally. Diagnostic inaccuracies and …

BACKGROUND: To reduce transmission and improve patient outcomes, rapid diagnosis
and treatment of rifampicin-resistant tuberculosis (RR-TB) is required. OBJECTIVE: To …

Background Patient-centered care is pillar 1 of the “End TB” strategy, but little has been
documented in the literature about what this means for people living with rifampicin-resistant …

Treatment for drug-resistant tuberculosis is largely delivered through standardised, empirical
combination regimens in low-resource, high-burden settings. However, individualised …

Defining occupational latent tuberculosis infection (LTBI) risk among healthcare workers is
needed to support implementation of prevention guidelines. Prospective cohort study of 200 …

To evaluate the diagnostic accuracy of matrix-assisted laser desorption ionization time-of-
flight mass spectrometry based on nucleotide (nucleotide MALDI-TOF MS) on …